Mazyar Shadman, MD, MPH
Mazyar Shadman, MD, MPH
- Physician, Fred Hutch
- Associate Professor, Division of Medical Oncology, University of Washington School of Medicine
- Associate Professor, Clinical Research Division, Fred Hutch
- Innovators Network Endowed Chair, Fred Hutch
Medical Oncology
“Your positive attitude and willingness to fight have always inspired me.”
— Dr. Shadman
What do you enjoy about being an academic physician?
Every day, I get to integrate science with the art of human interaction. Seeing patients benefit from medical advances, and being active in pushing the science forward, is extremely rewarding. It’s an exciting time for both cancer care and research. We now have access to a variety of novel therapies that enable us to target cancer cells more specifically without causing major side effects. In my field, we’re always looking for a “cure,” but in the meantime, I’m hopeful that we can relegate cancer to a chronic disease and help patients maintain their desired quality of life.
What is your role in cancer treatment?
A diagnosis of cancer kicks off a torrent of life changes, and in the middle of all this disruption are many important decisions to make about your care. My role is to help you thoroughly understand and weigh your options. At Fred Hutch, you have access to a variety of standard and experimental treatments, from chemotherapy to more novel, targeted approaches that may have fewer side effects. We’ll discuss each option in detail — the potential benefits, the risks and the overall impact on your life and family — so that you can make the best choices for your unique situation.
Provider Background
Specialty: Medical Oncology
Area of clinical practice
Adult Blood and Marrow Transplantation, Cellular Immunotherapy, Hematologic Malignancies
Lymphomas
I am a medical oncologist and stem-cell transplant expert who specializes in treating patients with lymphomas and other blood disorders. My clinical trial work focuses on testing novel agents for the treatment of leukemia and lymphoma, with a particular focus on chronic lymphocytic leukemia (CLL). I also study the clinical outcomes of patients who have already been treated. My goal is to identify patient- or disease-specific characteristics that can help us understand the behavior of a disease and predict its responsiveness to different treatments. One particular area of interest is the epidemiology of hematologic neoplasms (abnormal growth in blood-forming tissue). In 2013, I co-authored a study that found a correlation between certain types of allergies and blood cancers.
Diseases Treated
Diffuse Large B-cell Lymphoma
Lymphoma
Mantle Cell Lymphoma
Follicular Lymphoma
Low Grade Lymphoma
MALT Lymphoma
Marginal Zone Lymphoma
Languages
English
Persian
Education, Experience and Certifications
Medical Degree
Tehran University of Medical Sciences
Residency
Cleveland Clinic Foundation, Internal Medicine
Fellowship
University of Washington, Hematology-Oncology
Board Certification
Medical Oncology, 2014; Hematology, 2014; Internal Medicine, 2011, American Board of Internal Medicine
Other
MPH, University of Washington
Your Care Team
At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Insurance
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.
For the Media
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with providers.
Email media@fredhutch.org or call 206.667.2210